Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer

Yen Ching Chen, Huey-Jen Su, Yu Liang Leon Guo, E. Andres Houseman, David C. Christiani

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objective: Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. Methods: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancer patients and 202 fracture and cataract patients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. Results: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95% CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95% CI, 1.30-16.81) than in subjects with a high SMI. Conclusions: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.

Original languageEnglish
Pages (from-to)75-81
Number of pages7
JournalCancer Causes and Control
Volume16
Issue number2
DOIs
Publication statusPublished - 2005 Mar 1

Fingerprint

Arsenic
Urinary Bladder Neoplasms
Smoke
Methylation
Tobacco
Environmental Exposure
Drinking Water
Cataract

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Chen, Yen Ching ; Su, Huey-Jen ; Guo, Yu Liang Leon ; Houseman, E. Andres ; Christiani, David C. / Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. In: Cancer Causes and Control. 2005 ; Vol. 16, No. 2. pp. 75-81.
@article{a35b88ee88bc416a9240059747da7f6c,
title = "Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer",
abstract = "Objective: Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. Methods: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancer patients and 202 fracture and cataract patients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. Results: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95{\%} CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95{\%} CI, 1.30-16.81) than in subjects with a high SMI. Conclusions: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.",
author = "Chen, {Yen Ching} and Huey-Jen Su and Guo, {Yu Liang Leon} and Houseman, {E. Andres} and Christiani, {David C.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1007/s10552-004-2235-1",
language = "English",
volume = "16",
pages = "75--81",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "2",

}

Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. / Chen, Yen Ching; Su, Huey-Jen; Guo, Yu Liang Leon; Houseman, E. Andres; Christiani, David C.

In: Cancer Causes and Control, Vol. 16, No. 2, 01.03.2005, p. 75-81.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer

AU - Chen, Yen Ching

AU - Su, Huey-Jen

AU - Guo, Yu Liang Leon

AU - Houseman, E. Andres

AU - Christiani, David C.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Objective: Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. Methods: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancer patients and 202 fracture and cataract patients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. Results: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95% CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95% CI, 1.30-16.81) than in subjects with a high SMI. Conclusions: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.

AB - Objective: Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. Methods: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancer patients and 202 fracture and cataract patients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. Results: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95% CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95% CI, 1.30-16.81) than in subjects with a high SMI. Conclusions: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.

UR - http://www.scopus.com/inward/record.url?scp=18844452190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844452190&partnerID=8YFLogxK

U2 - 10.1007/s10552-004-2235-1

DO - 10.1007/s10552-004-2235-1

M3 - Article

VL - 16

SP - 75

EP - 81

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 2

ER -